Percutaneous therapy for treating patients with bony malignancy and vertebral fractures appears to significantly reduce costs and lengths of stay when compared with surgery. A retrospective review demonstrated that overall costs were $13,565 less and inpatient stays were 4.1 days shorter with percutaneous therapy when compared with surgery.
Abstract: Journal of Vascular and Interventional Radiology, November 2012.
